Amsalyo
Amsalyo is a cancer medicine used to treat acute myeloid leukemia by stopping cancer cell growth.
Form
kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos
Strength
75 mg
Active Ingredient
Amsacrine
Manufacturer
Eurocept International BV
How to Use
Dosage
Your doctor will determine the dose based on your general health and other treatments. Typically, 90-150 mg/m² daily for 3-5 consecutive days.
Method
The medicine is given slowly as an intravenous infusion, meaning a drip into a vein, over at least 60 minutes.
Important
The maximum daily dose is generally 150 mg/m².
Possible Side Effects
COMMON
- •Low blood pressure
- •Nausea, vomiting, or diarrhea
- •Abdominal pain
- •Mouth inflammation
- •Red spots on skin (purpura)
- •Local vein inflammation at injection site
- •Increased liver enzymes
RARE
- •Decreased red and white blood cells (anemia and increased infection risk)
- •Allergic reactions, severe allergic reactions, swelling
- •Weight loss or gain
- •Severe fatigue (lethargy), confusion
- •Headache
- •Vision problems
Important Warnings
- Do not use Amsalyo if you are allergic to amsacrine or any other ingredients in this medicine.
- This medicine can lower your white blood cell and platelet counts, increasing the risk of infections and bleeding. Your doctor will monitor your blood levels.
- Tell your doctor if you have kidney or liver problems, as your dose may need to be adjusted.
- Low potassium or magnesium levels in your blood must be corrected before treatment. Your heart rate will be monitored due to the risk of rhythm disturbances.
- Do not use this medicine if you are pregnant, breastfeeding, or planning to become pregnant, unless directed by your doctor. Use effective contraception during and after treatment.
Show 1 more warnings
- This medicine may cause dizziness, vision problems, or confusion. Do not drive or operate machinery if you experience these symptoms.